106 related articles for article (PubMed ID: 657448)
1. The pressor response to angiotensin II in patients with low renin essential hypertension.
Marks AD; Marks DB; Kim YN; Moctezuma J; Adlin EV; Channick BJ
Circ Res; 1978 Jun; 42(6):864-9. PubMed ID: 657448
[TBL] [Abstract][Full Text] [Related]
2. Urinary kallikrein excretion in essential and mineralocorticoid hypertension.
Holland OB; Chud JM; Braunstein H
J Clin Invest; 1980 Feb; 65(2):347-56. PubMed ID: 7356684
[TBL] [Abstract][Full Text] [Related]
3. Aldosterone responsiveness to angiotensin II after sodium restriction in subjects with low renin essential hypertension.
Takeda R; Morimoto S; Uchida K; Hashiba T; Kigoshi T; Honjo A; Fujimura A
Clin Exp Hypertens A; 1982; 4(6):937-49. PubMed ID: 7047005
[TBL] [Abstract][Full Text] [Related]
4. [Studies on abnormalities of adrenal steroidogenesis in essential hypertension, primary aldosteronism and renovascular hypertension: responses of plasma steroids to angiotensin III].
Itoh N
Nihon Naibunpi Gakkai Zasshi; 1988 May; 64(5):419-38. PubMed ID: 3410145
[TBL] [Abstract][Full Text] [Related]
5. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
Witzgall H; Lorenz R; von Werder K; Weber PC
Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
[TBL] [Abstract][Full Text] [Related]
6. Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension.
Fisher ND; Hurwitz S; Ferri C; Jeunemaitre X; Hollenberg NK; Williams GH
Hypertension; 1999 Sep; 34(3):388-94. PubMed ID: 10489382
[TBL] [Abstract][Full Text] [Related]
7. On the pathogenesis of Bartter's syndrome: report of studies in a patient with this disorder.
Norby L; Mark AL; Kaloyanides GJ
Clin Nephrol; 1976 Sep; 6(3):404-13. PubMed ID: 991467
[TBL] [Abstract][Full Text] [Related]
8. Body-sodium and blood volume in a patient with licorice-induced hypertension.
Beretta-Piccoli C; Salvadé G; Crivelli PL; Weidmann P
J Hypertens; 1985 Feb; 3(1):19-23. PubMed ID: 3889147
[TBL] [Abstract][Full Text] [Related]
9. Pressor factors and cardiovascular pressor responsiveness in borderline hypertension.
Meier A; Weidmann P; Grimm M; Keusch G; Glück Z; Minder I; Ziegler WH
Hypertension; 1981; 3(3):367-72. PubMed ID: 7019068
[TBL] [Abstract][Full Text] [Related]
10. Studies of the renin-angiotensin-aldosterone system in patients with hypertension and in normal subjects.
Streeten DH; Schletter FE; Clift GV; Stevenson CT; Dalakos TG
Am J Med; 1969 Jun; 46(6):844-61. PubMed ID: 4307877
[No Abstract] [Full Text] [Related]
11. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
[TBL] [Abstract][Full Text] [Related]
12. Pressor factors and responsiveness in hypertension accompanying diabetes mellitus.
Weidmann P; Beretta-Piccoli C; Trost BN
Hypertension; 1985; 7(6 Pt 2):II33-42. PubMed ID: 3908320
[TBL] [Abstract][Full Text] [Related]
13. TASK-3 channel deletion in mice recapitulates low-renin essential hypertension.
Guagliardo NA; Yao J; Hu C; Schertz EM; Tyson DA; Carey RM; Bayliss DA; Barrett PQ
Hypertension; 2012 May; 59(5):999-1005. PubMed ID: 22493079
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone regulation in essential hypertension: altered adrenal responsiveness to angiotensin II.
Williams GH; Dluhy RG; Moore TJ
Mayo Clin Proc; 1977 May; 52(5):312-6. PubMed ID: 870773
[TBL] [Abstract][Full Text] [Related]
15. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
Wisgerhof M; Brown RD
J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608
[TBL] [Abstract][Full Text] [Related]
16. Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism.
Wisgerhof M; Carpenter PC; Brown RD
J Clin Endocrinol Metab; 1978 Nov; 47(5):938-43. PubMed ID: 400738
[TBL] [Abstract][Full Text] [Related]
17. Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man.
Hollenberg NK; Williams GH; Burger B; Ishikawa I; Adams DF
J Clin Invest; 1976 Jan; 57(1):39-46. PubMed ID: 1245602
[TBL] [Abstract][Full Text] [Related]
18. Urinary kallikrein excretion in Bartter's syndrome.
Lechi A; Covi G; Lechi C; Mantero F; Scuro LA
J Clin Endocrinol Metab; 1976 Nov; 43(5):1175-8. PubMed ID: 993321
[TBL] [Abstract][Full Text] [Related]
19. QT interval in patients with primary aldosteronism and low-renin essential hypertension.
Maule S; Mulatero P; Milan A; Leotta G; Caserta M; Bertello C; Rabbia F; Veglio F
J Hypertens; 2006 Dec; 24(12):2459-64. PubMed ID: 17082730
[TBL] [Abstract][Full Text] [Related]
20. Similarity of idiopathic aldosteronism and essential hypertension. A statistical comparison.
McAreavey D; Murray GD; Lever AF; Robertson JI
Hypertension; 1983; 5(1):116-21. PubMed ID: 6336718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
